Royce Lee1, Craig Ferris, L D Van de Kar, Emil F Coccaro. 1. Clinical Neuroscience and Psychopharmacology Research Unit, Department of Psychiatry, The Pritzker School of Medicine, The University of Chicago, Chicago, IL 60637, USA. rlee@yoda.bsd.uchicago.edu
Abstract
BACKGROUND: Data from animal studies have identified oxytocin as an important modulator of social aggression. We have previously reported on a relationship between cerebrospinal fluid (CSF) levels of vasopressin and life history of aggressive behavior, a finding that is consistent with animal data. We hypothesized that CSF Oxytocin levels would be inversely related to dimensional measures of lifetime aggression. METHODS: Lumbar CSF for morning basal levels of oxytocin was obtained from 58 consenting subjects with and without DSM-IV personality disorders. Aggression was assessed dimensionally using an interview instrument (Life History of Aggression (LHA)). The primary analysis was conducted using a linear regression model predicting variance in CSF Oxytocin concentration, including the predictors of LHA score, Sex, Height, and the presence or absence of personality disorder. RESULTS: The model predicting variance in CSF Oxytocin concentration including LHA score was statistically significant, after removal of a single multivariate outlier. Inclusion of the outlier resulted in a most likely spurious interaction between Sex and LHA score. Presence or absence of personality disorder was not associated with variance in CSF Oxytocin levels. Exploratory analyses revealed a possible inverse relationship between CSF Oxytocin level and history of suicidal behavior. CONCLUSIONS: As hypothesized, CSF Oxytocin levels were inversely correlated with life history of aggression. This represents the first such report of a relationship between oxytocin levels and aggression. The correlational, cross-sectional study design precludes causal inferences, but the data are consistent with the known effects of oxytocin on aggressive behavior in animals.
BACKGROUND: Data from animal studies have identified oxytocin as an important modulator of social aggression. We have previously reported on a relationship between cerebrospinal fluid (CSF) levels of vasopressin and life history of aggressive behavior, a finding that is consistent with animal data. We hypothesized that CSF Oxytocin levels would be inversely related to dimensional measures of lifetime aggression. METHODS: Lumbar CSF for morning basal levels of oxytocin was obtained from 58 consenting subjects with and without DSM-IV personality disorders. Aggression was assessed dimensionally using an interview instrument (Life History of Aggression (LHA)). The primary analysis was conducted using a linear regression model predicting variance in CSF Oxytocin concentration, including the predictors of LHA score, Sex, Height, and the presence or absence of personality disorder. RESULTS: The model predicting variance in CSF Oxytocin concentration including LHA score was statistically significant, after removal of a single multivariate outlier. Inclusion of the outlier resulted in a most likely spurious interaction between Sex and LHA score. Presence or absence of personality disorder was not associated with variance in CSF Oxytocin levels. Exploratory analyses revealed a possible inverse relationship between CSF Oxytocin level and history of suicidal behavior. CONCLUSIONS: As hypothesized, CSF Oxytocin levels were inversely correlated with life history of aggression. This represents the first such report of a relationship between oxytocin levels and aggression. The correlational, cross-sectional study design precludes causal inferences, but the data are consistent with the known effects of oxytocin on aggressive behavior in animals.
Authors: Shun-Chiao Chang; M Maria Glymour; Marissa Rewak; Marilyn C Cornelis; Stefan Walter; Karestan C Koenen; Ichiro Kawachi; Liming Liang; Eric J Tchetgen Tchetgen; Laura D Kubzansky Journal: Psychoneuroendocrinology Date: 2013-10-01 Impact factor: 4.905
Authors: Kaeli W Yuen; Joseph P Garner; Dean S Carson; Jennifer Keller; Anna Lembke; Shellie A Hyde; Heather A Kenna; Lakshika Tennakoon; Alan F Schatzberg; Karen J Parker Journal: J Psychiatr Res Date: 2013-12-28 Impact factor: 4.791
Authors: Amanda J Myers; Leanne Williams; Justine M Gatt; Erica Z McAuley-Clark; Carol Dobson-Stone; Peter R Schofield; Charles B Nemeroff Journal: J Psychiatr Res Date: 2014-09-16 Impact factor: 4.791
Authors: D Hovey; M Lindstedt; A Zettergren; L Jonsson; A Johansson; J Melke; N Kerekes; H Anckarsäter; P Lichtenstein; S Lundström; L Westberg Journal: Mol Psychiatry Date: 2015-09-22 Impact factor: 15.992